Phase I evaluation of an immunogenic cell death inducer for transdermally accessible tumors June 30, 2014
Phase I and expansion cohort results presented for a yeast-based therapeutic cancer vaccine June 25, 2014
Enrollment complete in phase IIa trial of GALE-301 immunotherapy in gynecological cancer June 19, 2014
VGX-100 shows promise as monotherapy or as combination with bevacizumab in first-in-human trial June 13, 2014
RSS